What’s on the horizon?

What's on the horizon?It is 2025, a quarter of the way through the 21st century, and we are on the cusp of an acceleration in the role of artificial intelligence in science.ImmunoHorizons was launched in 2017 and is now entering its ninth year.Nine-year-olds today are immersed in technology, and in their world at their fingertips they have instant access to information and technology that can solve problems for them.As the incoming Editor-and-Chief of ImmunoHorizons, it will be my responsibility to mature the journal and guide it into this new era.To accomplish this, a new slate of Section Editors will help steer the journal, and the new publishing agreement with Oxford University Press will bring new opportunities for growth.However, we cannot accomplish this alone.ImmunoHorizons is the American Association of Immunologists' (AAI) open access journal that is uniquely positioned to provide timely content of interest to scientists interested in immunology.Given that the immune system plays a role in almost every organ, system, and disease in the body, advances in immunology are increasingly cross-disciplinary.My vision for the ImmunoHorizons of tomorrow is for it to be the go-to journal for the latest in immunology advances with content geared not only to "cardcarrying" immunologists, but also to investigators whose research brings them to immunology.In other words, let's bring immunology to the masses making immunology accessible to all.This growth will take a continued commitment from the AAI and its members.